FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Chadwick

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Geographic Areas

Great Britain

Co-author Network

Publications

TOP 3
David Kay; S Anthony; John Crowther; B J Chambers; F A Nicholson; David W Chadwick; Carl Stapleton; Mark D Wyer
Microbial water pollution: a screening tool for initial catchment-scale assessment and source apportionment.
David W Chadwick
NICE and neurology.
Siobhan Quenby; Sheba Anin; MD Bates; David W Chadwick; Gill Vince; Jim Neilson
Phenytoin but not valproate directly affected in vitro trophoblast differentiation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Chadwick (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: David Kay; S Anthony; John Crowther; B J Chambers; F A Nicholson; David W Chadwick; Carl Stapleton; Mark D Wyer
Microbial water pollution: a screening tool for initial catchment-scale assessment and source apportionment.
The Science of the total environment 2010;408(23):5649-56.
2009: David W Chadwick
NICE and neurology.
Practical neurology 2009;9(5):278-83.
2008: Siobhan Quenby; Sheba Anin; MD Bates; David W Chadwick; Gill Vince; Jim Neilson
Phenytoin but not valproate directly affected in vitro trophoblast differentiation.
European journal of obstetrics, gynecology, and reproductive biology 2008;137(1):31-6.
2008: David W Chadwick; Gus A Baker; Ann Jacoby; Anthony G Marson; Philip E M Smith
What is the optimal management of partial epilepsy uncontrolled by a first choice anticonvulsant?
BMJ (Clinical research ed.) 2008;337():a2199.
2008: David W Chadwick
The treatment of the first seizure: the benefits.
Epilepsia 2008;49 Suppl 1():26-8.
2007: Guy Leschziner; Andrea L Jorgensen; Toby Andrew; Paula R Williamson; Anthony G Marson; Alison J Coffey; Claire Middleditch; David J Balding; Jane Rogers; David R Bentley; David W Chadwick; Michael R Johnson; Munir Pirmohamed
The association between polymorphisms in RLIP76 and drug response in epilepsy.
Pharmacogenomics 2007;8(12):1715-22.
2007: Anthony G Marson; Richard E Appleton; Gus A Baker; David W Chadwick; Julie Doughty; Barbara Eaton; Carrol Gamble; Ann Jacoby; Phil Shackley; David F Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
Health technology assessment (Winchester, England) 2007;11(37):iii-iv, ix-x, 1-134.
2007: David W Chadwick; Tony Marson
Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients.
Epilepsia 2007;48(7):1259-63.
2007: Sanjay Sisodiya; J Helen Cross; Ingmar Blümcke; David W Chadwick; John Craig; Peter B Crino; Paul Debenham; Norman Delanty; Frances Elmslie; Mark Gardiner; Jeffrey Golden; David Goldstein; David A Greenberg; Renzo Guerrini; Michael Hanna; John Harris; Paul Harrison; Michael R Johnson; George Kirov; Dimitri M Kullman; Andrew Makoff; Carla Marini; Rima Nabbout; Lina Nashef; Jeffrey L Noebels; Ruth Ottman; Munir Pirmohamed; Asla Pitkänen; Ingrid Scheffer; Simon Shorvon; Graeme Sills; Nicholas Wood; Sameer Zuberi
Genetics of epilepsy: epilepsy research foundation workshop report.
Epileptic disorders : international epilepsy journal with videotape 2007;9(2):194-236.
2007: Ann Jacoby; Carrol Gamble; J Doughty; Anthony G Marson; David W Chadwick
Quality of life outcomes of immediate or delayed treatment of early epilepsy and single seizures.
Neurology 2007;68(15):1188-96.
2007: Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard E Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
Lancet 2007;369(9566):1016-26.
2007: Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard E Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.
Lancet 2007;369(9566):1000-15.
2007: Guy Leschziner; Toby Andrew; John Paul Leach; David W Chadwick; Alison J Coffey; David J Balding; David R Bentley; Munir Pirmohamed; Michael R Johnson
Common ABCB1 polymorphisms are not associated with multidrug resistance in epilepsy using a gene-wide tagging approach.
Pharmacogenetics and genomics 2007;17(3):217-20.
2007: Catrin Tudur Smith; Anthony G Marson; David W Chadwick; Paula R Williamson
Multiple treatment comparisons in epilepsy monotherapy trials.
Trials 2007;8():34.
2006: A G Marson; P R Williamson; S Taylor; M Maguire; David W Chadwick
Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures.
Neurology 2006;67(10):1872-5.
2006: Ana Alfirevic; Andrea L Jorgensen; Paula R Williamson; David W Chadwick; B Kevin Park; Munir Pirmohamed
HLA-B locus in Caucasian patients with carbamazepine hypersensitivity.
Pharmacogenomics 2006;7(6):813-8.
2006: David W Chadwick; Michael Privitera
How skeptical should we be about industry-sponsored studies?
Neurology 2006;67(3):378-9.
2006: Guy Leschziner; Andrea L Jorgensen; Toby Andrew; Munir Pirmohamed; Paula R Williamson; Anthony G Marson; Alison J Coffey; Claire Middleditch; Jane Rogers; David R Bentley; David W Chadwick; David J Balding; Michael R Johnson
Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study.
Lancet neurology 2006;5(8):668-76.
2006: Helen L Fowler; Gus A Baker; Jason Tipples; Dougal J Hare; Smon Keller; David W Chadwick; Andy Young
Recognition of emotion with temporal lobe epilepsy and asymmetrical amygdala damage.
Epilepsy & behavior : E&B 2006;9(1):164-72.
2006: Tracy A Glauser; Elinor Ben-Menachem; Blaise Bourgeois; Avital Cnaan; David W Chadwick; Carlos Guerreiro; Reetta Kalviainen; Richard H Mattson; Emilio Perucca; Torbjorn Tomson
ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
Epilepsia 2006;47(7):1094-120.
2006: Carrol Gamble; Paula R Williamson; David W Chadwick; Anthony G Marson
A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy.
Neurology 2006;66(9):1310-7.
2006: Lois G Kim; Tony L Johnson; Anthony G Marson; David W Chadwick
Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial.
Lancet neurology 2006;5(4):317-22.
2006: Ana Alfirevic; Tracy Mills; Pauline Harrington; Tracy Pinel; James Sherwood; Ansar Jawaid; John C Smith; Ruth E March; Bryan J Barratt; David W Chadwick; B Kevin Park; Munir Pirmohamed
Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster.
Pharmacogenetics and genomics 2006;16(4):287-96.
2006: David W Chadwick
Starting and stopping treatment for seizures and epilepsy.
Epilepsia 2006;47 Suppl 1():58-61.
2006: Dougall McCorry; Andrew Nicolson; D Smith; A Marson; Richard G Feltbower; David W Chadwick
An association between type 1 diabetes and idiopathic generalized epilepsy.
Annals of neurology 2006;59(1):204-6.
2005: Neil Hawkins; David Epstein; Michael Drummond; Jennifer Wilby; Anita Kainth; David W Chadwick; Mark J Sculpher
Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model.
Medical decision making : an international journal of the Society for Medical Decision Making 2005;25(5):493-510.
2005: Jacqueline A French; David W Chadwick
Antiepileptic drugs for the elderly: using the old to focus on the new.
Neurology 2005;64(11):1834-5.
2005: Anthony G Marson; Ann Jacoby; A Johnson; L Kim; Carrol Gamble; David W Chadwick
Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial.
Lancet 2005;365(9476):2007-13.
2005: Andrew Owen; Chris Goldring; Paul Morgan; David W Chadwick; B Kevin Park; Munir Pirmohamed
Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.
British journal of clinical pharmacology 2005;59(3):365-70.
2005: David W Chadwick; A G Marson
Zonisamide add-on for drug-resistant partial epilepsy.
Cochrane database of systematic reviews (Online) 2005;(4):CD001416.
2004: Dougall McCorry; David W Chadwick; Anthony Marson
Current drug treatment of epilepsy in adults.
Lancet neurology 2004;3(12):729-35.
2004: Naghme Adab; Usha Kini; J Vinten; J Ayres; G Baker; Jill Clayton-Smith; H Coyle; Alan Fryer; J Gorry; J Gregg; George Mawer; Paola Nicolaides; L Pickering; L Tunnicliffe; David W Chadwick
The longer term outcome of children born to mothers with epilepsy.
Journal of neurology, neurosurgery, and psychiatry 2004;75(11):1575-83.
2004: Athanasios Gaitatzis; Anthony L Johnson; David W Chadwick; Simon D Shorvon; Josemir W. Sander
Life expectancy in people with newly diagnosed epilepsy.
Brain : a journal of neurology 2004;127(Pt 11):2427-32.
2004: Dougall McCorry; David W Chadwick; P Barber; P M Cooper; S Wroe
Cough syncope in Heavy Goods Vehicle drivers.
QJM : monthly journal of the Association of Physicians 2004;97(9):631-2.
2004: Andrew Nicolson; David W Chadwick; David F Smith
The coexistence of idiopathic generalized epilepsy and partial epilepsy.
Epilepsia 2004;45(6):682-5.
2004: Markus Reuber; G A Baker; R Gill; D F Smith; David W Chadwick
Failure to recognize psychogenic nonepileptic seizures may cause death.
Neurology 2004;62(5):834-5.
2004: Andrew Nicolson; Richard E Appleton; David W Chadwick; David F Smith
The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies.
Journal of neurology, neurosurgery, and psychiatry 2004;75(1):75-9.
2004: Andrew Nicolson; David W Chadwick; David F Smith
A comparison of adult onset and "classical" idiopathic generalised epilepsy.
Journal of neurology, neurosurgery, and psychiatry 2004;75(1):72-4.
2003: Ettore Beghi; Giuliana Gatti; Clara Tonini; Elinor Ben-Menachem; David W Chadwick; Marina Nikanorova; Sergei A Gromov; Philip E M Smith; Luigi Maria Specchio; Emilio Perucca
Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial.
Epilepsy research 2003;57(1):1-13.
2003: Dennis R Doose; Martin J Brodie; Elaine A Wilson; David W Chadwick; John Oxbury; David J Berry; Stefan Schwabe; Meir Bialer
Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients.
Epilepsia 2003;44(7):917-22.
2003: Dean J Naisbitt; John Farrell; Gavin Wong; Jan P H Depta; Charlotte C Dodd; Josephine E Hopkins; Claire A Gibney; David W Chadwick; Werner J Pichler; Munir Pirmohamed; B Kevin Park
Characterization of drug-specific T cells in lamotrigine hypersensitivity.
The Journal of allergy and clinical immunology 2003;111(6):1393-403.
2003: David W Chadwick; Richard Gray
Shared scheme for assessing drugs for multiple sclerosis: dealing with uncertainties about cost effectiveness of treatments is difficult problem.
BMJ (Clinical research ed.) 2003;326(7400):1212-3.
2003: David W Chadwick; Peter Wolf
Meeting the challenge of treating epilepsy.
Epileptic disorders : international epilepsy journal with videotape 2003;5 Suppl 1():S7-8.
2003: Michael D Privitera; M J Brodie; R H Mattson; David W Chadwick; W Neto; S Wang
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy.
Acta neurologica Scandinavica 2003;107(3):165-75.
2003: Dean J Naisbitt; Markus Britschgi; G Wong; John Farrell; Jan P H Depta; David W Chadwick; Werner J Pichler; Munir Pirmohamed; B Kevin Park
Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones.
Molecular pharmacology 2003;63(3):732-41.
2003: Udo C Wieshmann; Christine Denby; PR Eldridge; Neil Roberts; Clare E Mackay; J A Webb; B M Tedman; David W Chadwick; D F Smith
Foramen ovale recordings: a presurgical investigation in epilepsy.
European neurology 2003;49(1):3-7.
2002: Paula R Williamson; Helen E Clough; Jane L Hutton; Anthony G Marson; David W Chadwick
Statistical issues in the assessment of the evidence for an interaction between factors in epilepsy trials.
Statistics in medicine 2002;21(18):2613-22.
2002: Martin J Brodie; David W Chadwick; Henning Anhut; Andreas Otte; Silke-Lo Messmer; Stephen Maton; Wilhelm Sauermann; Guta Murray; Elizabeth A Garofalo
Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
Epilepsia 2002;43(9):993-1000.
2002: Andrew Nicolson; John Paul Leach; David W Chadwick; David F Smith
The legacy of vigabatrin in a regional epilepsy clinic.
Journal of neurology, neurosurgery, and psychiatry 2002;73(3):327-9.
2002: A S Chappell; Josemir W. Sander; M J Brodie; David W Chadwick; Alberto LLedo; D Zhang; J Bjerke; G M Kiesler; S Arroyo
A crossover, add-on trial of talampanel in patients with refractory partial seizures.
Neurology 2002;58(11):1680-2.
2002: Anthony G Marson; Paula R Williamson; Helen E Clough; Jane L Hutton; David W Chadwick
Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis.
Epilepsia 2002;43(5):505-13.
2002: Nichole Taske; Magali P Williamson; Andrew Makoff; Louise Bate; David Curtis; Michael Kerr; Marianne Juel Kjeldsen; Kiang An Pang; Anders Sundqvist; Mogens Laue Friis; David W Chadwick; Alan Richens; Athanasios Covanis; Manuela Santos; Alexis Arzimanoglou; Chrysostomos P Panayiotopoulos; William P Whitehouse; Michele Rees; R Mark Gardiner
Evaluation of the positional candidate gene CHRNA7 at the juvenile myoclonic epilepsy locus (EJM2) on chromosome 15q13-14.
Epilepsy research 2002;49(2):157-72.
2002: David W Chadwick; David Smith
The misdiagnosis of epilepsy.
BMJ (Clinical research ed.) 2002;324(7336):495-6.
2002: David W Chadwick; T A Betts; H G Boddie; P M Crawford; P Lindstrom; P K Newman; I Soryal; S Wroe; T A H Holdich
Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a Q.I.D. regimen.
Seizure : the journal of the British Epilepsy Association 2002;11(2):114-23.
2002: David W Chadwick; A G Marson
Zonisamide add-on for drug-resistant partial epilepsy.
Cochrane database of systematic reviews (Online) 2002;(2):CD001416.
2001: David W Chadwick
Driving restrictions and people with epilepsy.
Neurology 2001;57(10):1749-50.
2001: Anthony G Marson; Jane L Hutton; John Paul Leach; S Castillo; D Schmidt; S White; Rungsan Chaisewikul; M Privitera; David W Chadwick
Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review.
Epilepsy research 2001;46(3):259-70.
2001: David W Chadwick
Inpatient monotherapy studies in epilepsy: con.
Epilepsy & behavior : E&B 2001;2(4):324-6.
2001: David W Chadwick
Vagal-nerve stimulation for epilepsy.
Lancet 2001;357(9270):1726-7.
2001: D Smith; David W Chadwick
The management of epilepsy.
Journal of neurology, neurosurgery, and psychiatry 2001;70 Suppl 2():II15-21.
2001: David W Chadwick
Monotherapy comparative trials: equivalence and differences in clinical trials.
Epilepsy research 2001;45(1-3):101-3; discussion 105-7.
2001: Munir Pirmohamed; K Lin; David W Chadwick; B Kevin Park
TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients.
Neurology 2001;56(7):890-6.
2001: Andrew Owen; Munir Pirmohamed; Justice Tettey; Paul Morgan; David W Chadwick; B Kevin Park
Carbamazepine is not a substrate for P-glycoprotein.
British journal of clinical pharmacology 2001;51(4):345-9.
2001: G A Baker; A Jacoby; D Buck; J Brooks; P Potts; David W Chadwick
The quality of life of older people with epilepsy: findings from a UK community study.
Seizure : the journal of the British Epilepsy Association 2001;10(2):92-9.
2001: A G Marson; David W Chadwick
New drug treatments for epilepsy.
Journal of neurology, neurosurgery, and psychiatry 2001;70(2):143-7.
2001: N Adab; A Jacoby; D Smith; David W Chadwick
Additional educational needs in children born to mothers with epilepsy.
Journal of neurology, neurosurgery, and psychiatry 2001;70(1):15-21.
2000: Clare E Mackay; J A Webb; PR Eldridge; David W Chadwick; G H Whitehouse; Neil Roberts
Quantitative magnetic resonance imaging in consecutive patients evaluated for surgical treatment of temporal lobe epilepsy.
Magnetic resonance imaging 2000;18(10):1187-99.
2000: David W Chadwick; D Smith; P Crawford; B Harrison
Remacemide hydrochloride: a placebo-controlled, one month, double-blind assessment of its safety, tolerability and pharmacokinetics as adjunctive therapy in patients with epilepsy.
Seizure : the journal of the British Epilepsy Association 2000;9(8):544-50.
2000: S Ahmed; David W Chadwick; R J Walker
The management of alcohol-related seizures: an overview.
Hospital medicine (London, England : 1998) 2000;61(11):793-6.
2000: Albert P Aldenkamp; G Baker; O G Mulder; David W Chadwick; P Cooper; Jan C Doelman; R Duncan; C Gassmann-Mayer; G J de Haan; C Hughson; Jacques Hulsman; J Overweg; G Pledger; T W Rentmeester; H Riaz; S Wroe
A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.
Epilepsia 2000;41(9):1167-78.
2000: M Silverdale; John Paul Leach; David W Chadwick
New variant Creutzfeldt-Jakob disease presenting as localization-related epilepsy.
Neurology 2000;54(11):2188.
2000: Paula R Williamson; Anthony G Marson; C Tudur; Jane L Hutton; David W Chadwick
Individual patient data meta-analysis of randomized anti-epileptic drug monotherapy trials.
Journal of evaluation in clinical practice 2000;6(2):205-14.
2000: David W Chadwick; D B Clear; PR Eldridge; mallucci conor
Golf ball epilepsy.
Journal of neurology, neurosurgery, and psychiatry 2000;68(2):251-2.
2000: D Clear; David W Chadwick
Seizures provoked by blows to the head.
Epilepsia 2000;41(2):243-4.
2000: David W Chadwick
Seizures and epilepsy after traumatic brain injury.
Lancet 2000;355(9201):334-6.
2000: Anthony G Marson; Paula R Williamson; Jane L Hutton; Helen E Clough; David W Chadwick
Carbamazepine versus valproate monotherapy for epilepsy.
Cochrane database of systematic reviews (Online) 2000;(3):CD001030.
2000: Anthony G Marson; ZA Kadir; Jane L Hutton; David W Chadwick
Gabapentin add-on for drug-resistant partial epilepsy.
Cochrane database of systematic reviews (Online) 2000;(3):CD001415.
2000: David W Chadwick; A G Marson
Zonisamide for drug-resistant partial epilepsy.
Cochrane database of systematic reviews (Online) 2000;(2):CD001416.
2000: Anthony G Marson; ZA Kadir; Jane L Hutton; David W Chadwick
Gabapentin for drug-resistant partial epilepsy.
Cochrane database of systematic reviews (Online) 2000;(2):CD001415.
2000: E Beghi; S Brown; D Capurro; David W Chadwick; C M Cornaggia; H De Boer; L Garattini; A Hauser; S J Homsma; M Lazazzera; M Sillanpää; A E Sonnen; R Thorbecke
IBE Commission Report. 2nd Workshop on "Epilepsy, Risks, and Insurance".
Epilepsia 2000;41(1):110-2.
1999: Ian Wong; David W Chadwick; P B Fenwick; George Mawer; Josemir W. Sander
The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy.
Epilepsia 1999;40(10):1439-45.
1999: J Webb; A Guimond; PR Eldridge; David W Chadwick; J Meunier; J P Thirion; Neil Roberts
Automatic detection of hippocampal atrophy on magnetic resonance images.
Magnetic resonance imaging 1999;17(8):1149-61.
1999: David W Chadwick
Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group.
Lancet 1999;354(9172):13-9.
1999: Eugene H Herman; Jun Zhang; Steven E Lipshultz; Nader Rifai; David W Chadwick; K Takeda; Zu-Xi Yu; Victor J Ferrans
Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2237-43.
1999: David W Chadwick
The use of new antiepileptic drugs.
Journal of the Royal College of Physicians of London 1999;33(4):328-32.
1999: Mark Kellett; David F Smith; P A Stockton; David W Chadwick
Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic.
Journal of neurology, neurosurgery, and psychiatry 1999;66(6):759-63.
1999: A G Marson; David W Chadwick
Report of a pragmatic trial comparing clobazam and "standard" treatment in childhood epilepsy.
Epilepsia 1999;40(4):531-3.
1999: John Paul Leach; David W Chadwick; John B Miles; Ian K Hart
Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy.
Neurology 1999;52(4):738-42.
1999: David W Chadwick; M Privitera
Placebo-controlled studies in neurology: where do they stop?
Neurology 1999;52(4):682-5.
1999: David W Chadwick
Does withdrawal of different antiepileptic drugs have different effects on seizure recurrence? Further results from the MRC Antiepileptic Drug Withdrawal Study.
Brain : a journal of neurology 1999;122 ( Pt 3)():441-8.
1999: ZA Kadir; David W Chadwick
Principles of treatment of epilepsy.
Drugs of today (Barcelona, Spain : 1998) 1999;35(1):35-41.
1999: D Smith; B A Defalla; David W Chadwick
The misdiagnosis of epilepsy and the management of refractory epilepsy in a specialist clinic.
QJM : monthly journal of the Association of Physicians 1999;92(1):15-23.
1998: David W Chadwick; D Smith
Epileptology of the first-seizure presentation.
Lancet 1998;352(9143):1855; author reply 1856.
1998: David W Chadwick; Henning Anhut; MJ Greiner; J Alexander; G H Murray; Elizabeth A Garofalo; M W Pierce
A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.
Neurology 1998;51(5):1282-8.
1998: H C Cochrane; A G Marson; G A Baker; David W Chadwick
Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards.
Epilepsia 1998;39(10):1088-97.
1998: David W Chadwick
Do new antiepileptic drugs justify their expense?
Archives of neurology 1998;55(8):1140-2.
1998: G P Rao; F A Fat; G Kyle; John Paul Leach; David W Chadwick; M Batterbury
Study is needed of visual field defects associated with any long term antiepileptic drug.
BMJ (Clinical research ed.) 1998;317(7152):206.
1998: Ann Jacoby; D Buck; G Baker; Paul McNamee; S Graham-Jones; David W Chadwick
Uptake and costs of care for epilepsy: findings from a U.K. regional study.
Epilepsia 1998;39(7):776-86.
1998: Gus A Baker; D F Smith; A Jacoby; J A Hayes; David W Chadwick
Liverpool Seizure Severity Scale revisited.
Seizure : the journal of the British Epilepsy Association 1998;7(3):201-5.
1998: Barbara G Vickrey; David R Gifford; Thomas R Belin; P J Martin; D Smith; S Delrahim; David W Chadwick
Practice styles of US compared to UK neurologists.
Neurology 1998;50(6):1661-8.
1998: Reetta Kälviäinen; M J Brodie; J Duncan; David W Chadwick; D Edwards; K Lyby
A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.
Epilepsy research 1998;30(1):31-40.
1998: A G Marson; David W Chadwick
Studies of drugs in epilepsy cited by author are not evidence based.
BMJ (Clinical research ed.) 1998;316(7132):703.
1997: David W Chadwick
Better comparisons of antiepileptic drugs: what measures of efficacy?
Pharmacy world & science : PWS 1997;19(5):214-6.
1997: David W Chadwick
Not everything that jerks is epilepsy.
British journal of sports medicine 1997;31(3):173.
1997: Anthony G Marson; ZA Kadir; Jane L Hutton; David W Chadwick
The new antiepileptic drugs: a systematic review of their efficacy and tolerability.
Epilepsia 1997;38(8):859-80.
1997: Frances V Elmslie; Michele Rees; Magali P Williamson; M Kerr; Marianne Juel Kjeldsen; K A Pang; A Sundqvist; Mogens Laue Friis; David W Chadwick; Alan Richens; Athanasios Covanis; M Santos; Alexis Arzimanoglou; Chrysostomos P Panayiotopoulos; David Curtis; William P Whitehouse; R Mark Gardiner
Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q.
Human molecular genetics 1997;6(8):1329-34.
1997: Mark Kellett; David F Smith; G A Baker; David W Chadwick
Quality of life after epilepsy surgery.
Journal of neurology, neurosurgery, and psychiatry 1997;63(1):52-8.
1997: A Marson; Z Kadir; David W Chadwick
Large pragmatic randomised studies of new antiepileptic drugs are needed.
BMJ (Clinical research ed.) 1997;314(7096):1764.
1997: David W Chadwick; E H Reynolds
Services for epilepsy in the United Kingdom.
Neurology 1997;48(6 Suppl 8):S3-7.
1997: David W Chadwick
Concussive convulsions. Wrong diagnosis may deprive people of their livelihood.
BMJ (Clinical research ed.) 1997;314(7089):1283.
1997: D Buck; A Jacoby; Gus A Baker; David W Chadwick
Factors influencing compliance with antiepileptic drug regimes.
Seizure : the journal of the British Epilepsy Association 1997;6(2):87-93.
1997: D Buck; Gus A Baker; Ann Jacoby; D F Smith; David W Chadwick
Patients' experiences of injury as a result of epilepsy.
Epilepsia 1997;38(4):439-44.
1997: Richard E Appleton; David W Chadwick; A Sweeney
Managing the teenager with epilepsy: paediatric to adult care.
Seizure : the journal of the British Epilepsy Association 1997;6(1):27-30.
1997: David W Chadwick
Monotherapy clinical trials of new antiepileptic drugs: design, indications, and controversies.
Epilepsia 1997;38 Suppl 9():S16-20.
1997: R E Ashcroft; David W Chadwick; S R Clark; R H Edwards; L Frith; Jane L Hutton
Implications of socio-cultural contexts for the ethics of clinical trials.
Health technology assessment (Winchester, England) 1997;1(9):i-iv, 1-65.
1997: David W Chadwick
An overview of the efficacy and tolerability of new antiepileptic drugs.
Epilepsia 1997;38 Suppl 1():S59-62.
1996: G Schapel; David W Chadwick
A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
Seizure : the journal of the British Epilepsy Association 1996;5(4):267-70.
1996: A G Marson; ZA Kadir; David W Chadwick
New antiepileptic drugs: a systematic review of their efficacy and tolerability.
BMJ (Clinical research ed.) 1996;313(7066):1169-74.
1996: David W Chadwick; D B Leiderman; W Sauermann; J Alexander; Elizabeth A Garofalo
Gabapentin in generalized seizures.
Epilepsy research 1996;25(3):191-7.
1996: David W Chadwick
Quality of life measurements in epilepsy.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1996;23(4 Suppl 2):S3-5.
1996: David W Chadwick; J Taylor; T Johnson
Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC Antiepileptic Drug Withdrawal Group.
Epilepsia 1996;37(11):1043-50.
1996: Ann Jacoby; S Graham-Jones; G Baker; L Ratoff; J Heyes; M Dewey; David W Chadwick
A general practice records audit of the process of care for people with epilepsy.
The British journal of general practice : the journal of the Royal College of General Practitioners 1996;46(411):595-9.
1996: A Marson; E Beghi; A Berg; David W Chadwick; C Tonini
The Cochrane collaboration: systematic reviews and their relevance to epilepsy. The Cochrane Epilepsy Network.
Epilepsia 1996;37(10):917-21.
1996: Gus A Baker; Ann Jacoby; David W Chadwick
The associations of psychopathology in epilepsy: a community study.
Epilepsy research 1996;25(1):29-39.
1996: D Buck; Ann Jacoby; Gus A Baker; S Graham-Jones; David W Chadwick
Patients' experiences of and satisfaction with care for their epilepsy.
Epilepsia 1996;37(9):841-9.
1996: Frances V Elmslie; M P Williamson; Michele Rees; M Kerr; M J Kjeldsen; K A Pang; A Sundqvist; Mogens Laue Friis; A Richens; David W Chadwick; William P Whitehouse; R Mark Gardiner
Linkage analysis of juvenile myoclonic epilepsy and microsatellite loci spanning 61 cM of human chromosome 6p in 19 nuclear pedigrees provides no evidence for a susceptibility locus in this region.
American journal of human genetics 1996;59(3):653-63.
1996: G Schapel; David W Chadwick
Tiagabine and non-convulsive status epilepticus.
Seizure : the journal of the British Epilepsy Association 1996;5(2):153-6.
1996: J Taylor; David W Chadwick; T Johnson
Risk of accidents in drivers with epilepsy.
Journal of neurology, neurosurgery, and psychiatry 1996;60(6):621-7.
1996: A G Marson; David W Chadwick
Comparing antiepileptic drugs.
Current opinion in neurology 1996;9(2):103-6.
1996: A G Marson; David W Chadwick
How easy are randomized controlled trials in epilepsy to find on Medline? The sensitivity and precision of two Medline searches.
Epilepsia 1996;37(4):377-80.
1996: Ann Jacoby; Gus A Baker; Nick Steen; P Potts; David W Chadwick
The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study.
Epilepsia 1996;37(2):148-61.
1996: David W Chadwick; T Marson; ZA Kadir
Clinical administration of new antiepileptic drugs: an overview of safety and efficacy.
Epilepsia 1996;37 Suppl 6():S17-22.
1995: J Taylor; David W Chadwick; T Johnson
Accident experience and notification rates in people with recent seizures, epilepsy or undiagnosed episodes of loss of consciousness.
QJM : monthly journal of the Association of Physicians 1995;88(10):733-40.
1995: Jane L Hutton; D F Smith; David W Chadwick
Prospective evaluation of a prognostic index for intrinsic supratentorial tumours.
Journal of neurology, neurosurgery, and psychiatry 1995;59(1):92-4.
1995: Alan Richens; David W Chadwick; J S Duncan; Mogens Dam; L Gram; M Mikkelsen; J Morrow; H Mengel; V Shu; J F McKelvy
Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial.
Epilepsy research 1995;21(1):37-42.
1995: D Smith; Gus A Baker; Ann Jacoby; David W Chadwick
The contribution of the measurement of seizure severity to quality of life research.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1995;4(2):143-58.
1995: AK Wagner; SD Keller; M Kosinski; Gus A Baker; Ann Jacoby; M A Hsu; David W Chadwick; John Ware
Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1995;4(2):115-34.
1995: David W Chadwick
Do anticonvulsants alter the natural course of epilepsy? Case for early treatment is not established.
BMJ (Clinical research ed.) 1995;310(6973):177-8.
1995: A J Heller; P Chesterman; R D Elwes; P Crawford; David W Chadwick; A L Johnson; E H Reynolds
Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial.
Journal of neurology, neurosurgery, and psychiatry 1995;58(1):44-50.
1994: David W Chadwick
Driving after and during neurological disorders.
The Practitioner 1994;238(1545):830-3.
1994: David W Chadwick
Measuring antiepileptic therapies: the patient vs the physician viewpoint.
Neurology 1994;44(11 Suppl 8):S24-8.
1994: David W Chadwick
[Value of sodium valproate in the treatment of partial epilepsy].
Praxis 1994;83(40):1140-3.
1994: Munir Pirmohamed; R Allott; V J Green; Neil R Kitteringham; David W Chadwick; B Kevin Park
Lymphocyte microsomal epoxide hydrolase in patients on carbamazepine therapy.
British journal of clinical pharmacology 1994;37(6):577-81.
1994: P M Moore; Gus A Baker; G McDade; David W Chadwick; S Brown
Epilepsy, pseudoseizures and perceived family characteristics: a controlled study.
Epilepsy research 1994;18(1):75-83.
1994: Gus A Baker; Ann Jacoby; D F Smith; M E Dewey; David W Chadwick
Development of a novel scale to assess life fulfillment as part of the further refinement of a quality-of-life model for epilepsy.
Epilepsia 1994;35(3):591-6.
1994: David W Chadwick
New antiepileptic drugs.
The Quarterly journal of medicine 1994;87(3):139-41.
1994: David W Chadwick
Epilepsy.
Journal of neurology, neurosurgery, and psychiatry 1994;57(3):264-77.
1994: David W Chadwick
Gabapentin.
Lancet 1994;343(8889):89-91.
1994: David W Chadwick
Standard approach to antiepileptic drug treatment in the United Kingdom.
Epilepsia 1994;35 Suppl 4():S3-10.
1994: David W Chadwick
Valproate in the treatment of partial epilepsies.
Epilepsia 1994;35 Suppl 5():S96-8.
1993: Ann Jacoby; G Baker; David W Chadwick; A Johnson
The impact of counselling with a practical statistical model on patients' decision-making about treatment for epilepsy: findings from a pilot study.
Epilepsy research 1993;16(3):207-14.
1993: Ann Jacoby; G Baker; D Smith; M Dewey; David W Chadwick
Measuring the impact of epilepsy: the development of a novel scale.
Epilepsy research 1993;16(1):83-8.
1993: Gus A Baker; D F Smith; M Dewey; Ann Jacoby; David W Chadwick
The initial development of a health-related quality of life model as an outcome measure in epilepsy.
Epilepsy research 1993;16(1):65-81.
1993: David Gillatt; Colin Bolton; David W Chadwick; Lee Downs; Margaret Hopton; JC Gingell
Lipoprotein levels following treatment with cyproterone acetate or LHRH analogues.
British journal of urology 1993;71(6):728-30.
1993: S Brown; T Betts; David W Chadwick; B Hall; S Shorvon; S Wallace
An epilepsy needs document.
Seizure : the journal of the British Epilepsy Association 1993;2(2):91-103.
1993: Carolyn A Young; J M MacKenzie; David W Chadwick; I R Williams
Opsoclonus-myoclonus syndrome: an autopsy study of three cases.
The European journal of medicine 1993;2(4):239-41.
1993: D Smith; G Baker; G Davies; M Dewey; David W Chadwick
Outcomes of add-on treatment with lamotrigine in partial epilepsy.
Epilepsia 1993;34(2):312-22.
1993: E H Reynolds; A J Heller; David W Chadwick
Valproate versus carbamazepine for seizures.
The New England journal of medicine 1993;328(3):207-8; author reply 209.
1993: D Smith; David W Chadwick; G Baker; G Davis; M Dewey
Seizure severity and the quality of life.
Epilepsia 1993;34 Suppl 5():S31-5.
1992: A Jacoby; A Johnson; David W Chadwick
Psychosocial outcomes of antiepileptic drug discontinuation. The Medical Research Council Antiepileptic Drug Withdrawal Study Group.
Epilepsia 1992;33(6):1123-31.
1992: P M Foy; David W Chadwick; N Rajgopalan; A L Johnson; M D Shaw
Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy?
Journal of neurology, neurosurgery, and psychiatry 1992;55(9):753-7.
1992: David W Chadwick
Who needs neurological imaging?
Seizure : the journal of the British Epilepsy Association 1992;1(3):145-7.
1992: A Jacoby; David W Chadwick
Psychosocial problems in epilepsy.
BMJ (Clinical research ed.) 1992;305(6845):117.
1992: David W Chadwick
Neural tube defects in association with epilepsy and its treatment.
Pharmaceutisch weekblad. Scientific edition 1992;14(3A):126.
1992: Jane L Hutton; D F Smith; D Sandemann; P M Foy; M D Shaw; I R Williams; David W Chadwick
Development of prognostic index for primary supratentorial intracerebral tumours.
Journal of neurology, neurosurgery, and psychiatry 1992;55(4):271-4.
1992: K Ganabathi; David W Chadwick; Roger Feneley; JC Gingell
Haemospermia.
British journal of urology 1992;69(3):225-30.
1991: Munir Pirmohamed; A Graham; P Roberts; D Smith; David W Chadwick; Alasdair M Breckenridge; B Kevin Park
Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine.
British journal of clinical pharmacology 1991;32(6):741-9.
1991: D F Smith; Jane L Hutton; D Sandemann; P M Foy; M D Shaw; I R Williams; David W Chadwick
The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management.
Journal of neurology, neurosurgery, and psychiatry 1991;54(10):915-20.
1991: D F Smith; Gus A Baker; M Dewey; Ann Jacoby; David W Chadwick
Seizure frequency, patient-perceived seizure severity and the psychosocial consequences of intractable epilepsy.
Epilepsy research 1991;9(3):231-41.
1991: J E Kabala; David Gillatt; Rajendra A Persad; J B Penry; JC Gingell; David W Chadwick
Magnetic resonance imaging in the staging of renal cell carcinoma.
The British journal of radiology 1991;64(764):683-9.
1991: David W Chadwick
Epilepsy after first seizures: risks and implications.
Journal of neurology, neurosurgery, and psychiatry 1991;54(5):385-7.
1991: Carolyn A Young; David W Chadwick; P R Humphrey
Extracranial vertebral artery dissection following tonic clonic seizure.
Journal of neurology, neurosurgery, and psychiatry 1991;54(4):365-6.
1991: Gus A Baker; D F Smith; M Dewey; J Morrow; P M Crawford; David W Chadwick
The development of a seizure severity scale as an outcome measure in epilepsy.
Epilepsy research 1991;8(3):245-51.
1991: David W Chadwick
Gabapentin.
Epilepsy research. Supplement 1991;3():183-6.
1991: David W Chadwick
Tumour markers in screening.
The British journal of surgery 1991;78(1):121.
1990: David W Chadwick
Diagnosis of epilepsy.
Lancet 1990;336(8710):291-5.
1990: David W Chadwick; David Gillatt; JC Gingell; P H Abrams
Screening for carcinoma of the prostate.
BMJ (Clinical research ed.) 1990;301(6743):119-20.
1990: David W Chadwick
Prospects for new drug treatment in epilepsy: a review.
Journal of the Royal Society of Medicine 1990;83(6):383-6.
1990: S W Brown; G E Mawer; W Lawler; D C Taylor; S Shorvon; T A Betts; M J Noronha; A Richens; David W Chadwick; F M Besag
Sudden death and epilepsy.
Lancet 1990;335(8689):606-7.
1990: D R Sandeman; A P Sandeman; P Buxton; H H Hughes; David W Chadwick; I R Williams; R D Baker; P M Foy; D M Shaw
The management of patients with an intrinsic supratentorial brain tumour.
British journal of neurosurgery 1990;4(4):299-312.
1990: David W Chadwick
The epidemiology of drug resistant epilepsy and adverse effects of antiepileptic drugs.
Acta neurochirurgica. Supplementum 1990;50():32-7.
1990: David W Chadwick
Why are so few patients with epilepsy treated surgically? A United Kingdom perspective.
Acta neurochirurgica. Supplementum 1990;50():117-8.
1989: David W Chadwick
Epilepsy in women of childbearing age.
BMJ (Clinical research ed.) 1989;299(6708):1163-4.
1989: S J Howell; L Owen; David W Chadwick
Pseudostatus epilepticus.
The Quarterly journal of medicine 1989;71(266):507-19.
1989: J Miles; David W Chadwick
Surgery for temporal lobe epilepsy.
Lancet 1989;1(8630):161.
1989: P M Crawford; P Belchetz; C Davis; David W Chadwick
Growth hormone response to diazepam, clonidine and glucagon in patients with epilepsy.
Epilepsy research 1989;3(1):63-9.
1988: A Bowden; I R Williams; L D Blumhardt; G Findlay; David W Chadwick; P Foy; P R Humphrey; RV Jeffreys; B R Lecky; J B Miles
Consensus on HIV testing.
BMJ (Clinical research ed.) 1988;297(6650):740.
1988: P M Crawford; K G Lloyd; David W Chadwick
CSF gradients for amino acid neurotransmitters.
Journal of neurology, neurosurgery, and psychiatry 1988;51(9):1193-200.
1988: David W Chadwick
Drug withdrawal and epilepsy. When and how?
Drugs 1988;35(5):579-83.
1988: David W Chadwick
The modern treatment of epilepsy.
British journal of hospital medicine 1988;39(2):104-7, 110-1.
1988: David W Chadwick
Comparison of monotherapy with valproate and other antiepileptic drugs in the treatment of seizure disorders.
The American journal of medicine 1988;84(1A):3-6.
1988: P O'Neill; C R West; David W Chadwick; M Conway; P M Foy; P Maloney; J D Pickard; J A Spillane; M D Shaw
Recurrent aneurysmal subarachnoid haemorrhage: incidence, timing and effects. A re-appraisal in a surgical series.
British journal of neurosurgery 1988;2(1):43-8.
1988: P O'Neill; C R West; David W Chadwick; M Conway; P M Foy; P Maloney; J D Pickard; J A Spillane; M D Shaw
Post-ictal blood pressure in aneurysmal subarachnoid haemorrhage.
British journal of neurosurgery 1988;2(2):153-9.
1987: P M Crawford; David W Chadwick
GABA and amino acid concentrations in lumbar CSF in patients with treated and untreated epilepsy.
Epilepsy research 1987;1(6):328-38.
1987: T Betts; David W Chadwick; M Espir; M Parsonage; E Reynolds; S Shorvon; S Wallace
Another opportunity to improve epilepsy services should not be lost.
Journal of the Royal Society of Medicine 1987;80(10):604-5.
1987: P Crawford; E Ghadiali; R Lane; L Blumhardt; David W Chadwick
Gabapentin as an antiepileptic drug in man.
Journal of neurology, neurosurgery, and psychiatry 1987;50(6):682-6.
1987: David W Chadwick
Overuse of monitoring of blood concentrations of antiepileptic drugs.
British medical journal (Clinical research ed.) 1987;294(6574):723-4.
1987: P M Foy; M D Shaw; I R Williams; David W Chadwick
Neurological and neurosurgical approaches in the management of malignant brain tumours.
British medical journal (Clinical research ed.) 1987;294(6568):372.
1987: David W Chadwick
Valproate monotherapy in the management of generalized and partial seizures.
Epilepsia 1987;28 Suppl 2():S12-7.
1986: S J Wroe; P M Foy; M D Shaw; I R Williams; David W Chadwick; C West; G Towns
Neurological and neurosurgical approaches in the management of malignant brain tumours.
British medical journal (Clinical research ed.) 1986;293(6558):1373.
1986: P Crawford; David W Chadwick
A comparative study of progabide, valproate, and placebo as add-on therapy in patients with refractory epilepsy.
Journal of neurology, neurosurgery, and psychiatry 1986;49(11):1251-7.
1986: S J Wroe; P M Foy; M D Shaw; I R Williams; David W Chadwick; C West; G Towns
Differences between neurological and neurosurgical approaches in the management of malignant brain tumours.
British medical journal (Clinical research ed.) 1986;293(6553):1015-8.
1986: R N Baldwin; David W Chadwick
Lhermitte's "sign" due to thoracic cord compression.
Journal of neurology, neurosurgery, and psychiatry 1986;49(7):840-1.
1986: P M Crawford; C R West; M D Shaw; David W Chadwick
Cerebral arteriovenous malformations and epilepsy: factors in the development of epilepsy.
Epilepsia 1986;27(3):270-5.
1986: P M Crawford; C R West; David W Chadwick; M D Shaw
Arteriovenous malformations of the brain: natural history in unoperated patients.
Journal of neurology, neurosurgery, and psychiatry 1986;49(1):1-10.
1986: P Crawford; David W Chadwick; P Cleland; John F Tjia; A Cowie; David J Back; M L Orme
The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids.
Contraception 1986;33(1):23-9.
1986: David W Chadwick; Mark Hallett; Peter Jenner; CD Marsden
Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder.
Advances in neurology 1986;43():183-90.
1985: David W Chadwick; D M Turnbull
The comparative efficacy of antiepileptic drugs for partial and tonic-clonic seizures.
Journal of neurology, neurosurgery, and psychiatry 1985;48(11):1073-7.
1985: M D Shaw; P M Foy; M Conway; J D Pickard; P Maloney; J A Spillane; David W Chadwick
Dipyridamole and postoperative ischemic deficits in aneurysmal subarachnoid hemorrhage.
Journal of neurosurgery 1985;63(5):699-703.
1985: David W Chadwick; E H Reynolds
When do epileptic patients need treatment? Starting and stopping medication.
British medical journal (Clinical research ed.) 1985;290(6485):1885-8.
1985: D M Turnbull; D Howel; M D Rawlins; David W Chadwick
Which drug for the adult epileptic patient: phenytoin or valproate?
British medical journal (Clinical research ed.) 1985;290(6471):815-9.
1985: David W Chadwick
Concentration-effect relationships of valproic acid.
Clinical pharmacokinetics 1985;10(2):155-63.
1984: David W Chadwick; M D Shaw; P Foy; M D Rawlins; D M Turnbull
Serum anticonvulsant concentrations and the risk of drug induced skin eruptions.
Journal of neurology, neurosurgery, and psychiatry 1984;47(6):642-4.
1984: R J Greenwood; J Newsom-Davis; R A Hughes; S Aslan; A N Bowden; David W Chadwick; N S Gordon; D L McLellan; P Millac; R B Stott
Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy.
Lancet 1984;1(8382):877-9.
1984: D M Turnbull; M D Rawlins; D Weightman; David W Chadwick
"Therapeutic" serum concentration of phenytoin: the influence of seizure type.
Journal of neurology, neurosurgery, and psychiatry 1984;47(3):231-4.
1984: S N Marcus; David W Chadwick; R J Walker
D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis.
Gastroenterology 1984;86(1):166-8.
1983: David W Chadwick
Pharmacokinetics of anticonvulsants.
British journal of hospital medicine 1983;30(6):421-4.
1983: D M Turnbull; M D Rawlins; D Weightman; David W Chadwick
Plasma concentrations of sodium valproate: their clinical value.
Annals of neurology 1983;14(1):38-42.
1983: M D Shaw; P Foy; David W Chadwick
The effectiveness of prophylactic anticonvulsants following neurosurgery.
Acta neurochirurgica 1983;69(3-4):253-8.
1982: David W Chadwick; S Martin; P H Buxton; A H Tomlinson
Measles virus and subacute neurological disease: an unusual presentation of measles inclusion body encephalitis.
Journal of neurology, neurosurgery, and psychiatry 1982;45(8):680-4.
1982: David W Chadwick
Antibiotics and benign intracranial hypertension.
The Journal of antimicrobial chemotherapy 1982;9(2):88-90.
1982: D M Turnbull; M D Rawlins; D Weightman; David W Chadwick
A comparison of phenytoin and valproate in previously untreated adult epileptic patients.
Journal of neurology, neurosurgery, and psychiatry 1982;45(1):55-9.
1982: R Greenwood; J Newsom-Davis; R A Hughes; S Aslan; R B Stott; A N Bowden; David W Chadwick; D L McLellan; P Millac; N S Gordon; P Armitage
British multicentre trial of plasma exchange in acute inflammatory polyradiculoneuropathy (AIP).
Progress in clinical and biological research 1982;106():189-96.
1981: E H Reynolds; S D Shorvon; A W Galbraith; David W Chadwick; C I Dellaportas; L Vydelingum
Phenytoin monotherapy for epilepsy: a long-term prospective study, assisted by serum level monitoring, in previously untreated patients.
Epilepsia 1981;22(4):475-88.
1980: David W Chadwick; Mark Hallett; Peter Jenner; CD Marsden
Observations on chloralose-induced myoclonus in guinea-pigs.
British journal of pharmacology 1980;69(3):535-40.
1980: David W Chadwick; E Hartley; D M Mackinnon
Meningitis caused by Candida tropicalis.
Archives of neurology 1980;37(3):175-6.
1979: David W Chadwick; W J Cumming; I Livingstone; N E Cartlidge
Acute intoxication with sodium valproate.
Annals of neurology 1979;6(6):552-3.
1979: Mark Hallett; David W Chadwick; CD Marsden
Cortical reflex myoclonus.
Neurology 1979;29(8):1107-25.
1979: David W Chadwick; Peter Jenner; CD Marsden
5-Hydroxytryptamine and myoclonus induced by 1,2-di-hydroxybenzene (catechol) in the guinea-pig.
British journal of pharmacology 1979;66(3):358-60.
1979: David W Chadwick; A T French
Uraemic myoclonus: an example of reticular reflex myoclonus?
Journal of neurology, neurosurgery, and psychiatry 1979;42(1):52-5.
1978: S D Shorvon; David W Chadwick; A W Galbraith; E H Reynolds
One drug for epilepsy.
British medical journal 1978;1(6111):474-6.
1978: David W Chadwick; M Trimble; Peter Jenner; M V Driver; E H Reynolds
Manipulation of cerebral monoamines in the treatment of human epilepsy: a pilot study.
Epilepsia 1978;19(1):3-10.
1978: David W Chadwick; J W Gorrod; Peter Jenner; CD Marsden; E H Reynolds
Functional changes in cerebral 5-hydroxytryptamine metabolism in the mouse induced by anticonvulsant drugs.
British journal of pharmacology 1978;62(1):115-24.
1978: David W Chadwick; Mark Hallett; Peter Jenner; CD Marsden
5-hydroxytryptophan-induced myoclonus in guinea pigs. A physiological and pharmacological investigations.
Journal of the neurological sciences 1978;35(1):157-65.
1977: David W Chadwick; Mark Hallett; R Harris; Peter Jenner; E H Reynolds; CD Marsden
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
Brain : a journal of neurology 1977;100(3):455-87.
1977: Mark Hallett; David W Chadwick; CD Marsden
Ballistic movement overflow myoclonus a form of essential myoclonus.
Brain : a journal of neurology 1977;100(2):299-312.
1977: David W Chadwick; M Hallet; Peter Jenner; CD Marsden
5-Hydroxytryptophan-induced behaviour in guinea-pigs: its relevance to human myoclonus [proceedings].
British journal of clinical pharmacology 1977;4(3):402P-403P.
1977: David W Chadwick; Peter Jenner; E H Reynolds
Serotonin metabolism in human epilepsy: the influence of anticonvulsant drugs.
Annals of neurology 1977;1(3):218-24.
1977: Mark Hallett; David W Chadwick; J Adam; CD Marsden
Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus.
Journal of neurology, neurosurgery, and psychiatry 1977;40(3):253-64.
1977: P N Elliott; Peter Jenner; David W Chadwick; E Reynolds; CD Marsden
The effect of diphenylhydantoin on central catecholamine containing neuronal systems.
The Journal of pharmacy and pharmacology 1977;29(1):41-3.
1976: David W Chadwick; E H Reynolds; CD Marsden
Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics.
Journal of neurology, neurosurgery, and psychiatry 1976;39(12):1210-8.
1976: B D Ridge; E Fairhurst; David W Chadwick; E H Reynolds
Ascorbic acid concentrations in human plasma and cerebrospinal fluid [proceedings].
The Proceedings of the Nutrition Society 1976;35(2):57A-58A.
1976: E H Reynolds; David W Chadwick; A W Galbraith
One drug (phenytoin) in the treatment of epilepsy.
Lancet 1976;1(7966):923-6.
1975: E H Reynolds; David W Chadwick; Peter Jenner; I Chanarin
Folate and monoamine metabolism in epilepsy.
Journal of the neurological sciences 1975;26(4):605-15.
1975: Peter Jenner; David W Chadwick; E H Reynolds; CD Marsden
Proceedings: Clonazepam-induced changes in 5-hydroxytryptamine (5-HT) metabolism in aminals and man.
The Journal of pharmacy and pharmacology 1975;27 Suppl?-2():38P.
1975: David W Chadwick; Peter Jenner; R Harris; E H Reynolds; CD Marsden
Manipulation of brain serotonin in the treatment of myoclonus.
Lancet 1975;2(7932):434-5.
1975: Peter Jenner; David W Chadwick; E H Reynolds; CD Marsden
Altered 5-HT metabolism with clonazepam, diazepam and diphenylhydantoin.
The Journal of pharmacy and pharmacology 1975;27(9):707-10.
1975: David W Chadwick; Peter Jenner; E H Reynolds
Letter: Amines, anticonvulsants, and epilepsy.
Lancet 1975;1(7922):1425-6.
1975: P Asselman; David W Chadwick; D C Marsden
Visual evoked responses in the diagnosis and management of patients suspected of multiple sclerosis.
Brain : a journal of neurology 1975;98(2):261-82.
1975: M Trimble; David W Chadwick; E H Reynolds; CD Marsden
Letter: L 5-Hydroxytryptophan and mood.
Lancet 1975;1(7906):583.
1975: David W Chadwick; Peter Jenner; E H Reynolds
Amines, anticonvulsants, and epilepsy.
Lancet 1975;1(7905):473-6.
1974: David W Chadwick; E H Reynolds; CD Marsden
Letter: Relief of action myoclonus by 5-hydroxytryptophan.
Lancet 1974;2(7872):111-2.